Chronopharmacokinetics of Erlotinib and Circadian Rhythms of Related Metabolic Enzymes in Lewis Tumor-Bearing Mice

European Journal of Drug Metabolism and Pharmacokinetics

Volumn 41, Issue 5, 2016, Pages 627-635

  Liu, Jiao ^b   Wang, Chun Yan ^a   Ji, Song Gang ^a   Xu, Xia ^a   Wang, Pei Pei ^e   Zhang, Bin ^f   Zhao, Li Yan ^a   Liu, Liang ^c   Lin, Ping Ping ^c   Liu, Le Kun ^d   Li, Ming Chun ^a  

^a 401 Hospital of PLA   (China)

^b WEIFANG MEDICAL UNIVERSITY   (China)

^c QINGDAO UNIVERSITY MEDICAL COLLEGE   (China)

^d Weifang Institute of Dermatology   (China)

^e FUDAN UNIVERSITY   (China)

^f INSTITUTE OF MEDICINAL PLANT DEVELOPMENT   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 1A2; CYTOCHROME P450 3A11; CYTOCHROME P450 3A13; ERLOTINIB; MESSENGER RNA; UNCLASSIFIED DRUG;

ACCURACY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CIRCADIAN RHYTHM; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG DETERMINATION; DRUG EFFECT; FEMALE; GENE EXPRESSION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LEWIS CARCINOMA; MAXIMUM PLASMA CONCENTRATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; ANIMAL; C57BL MOUSE; CHRONOPHARMACOKINETICS; LIVER; METABOLISM; NEOPLASM; ORAL DRUG ADMINISTRATION; PHYSIOLOGY;

ADMINISTRATION, ORAL; ANIMALS; CHRONOPHARMACOKINETICS; CIRCADIAN RHYTHM; ERLOTINIB HYDROCHLORIDE; FEMALE; LIVER; MICE; MICE, INBRED C57BL; NEOPLASMS; RNA, MESSENGER;

EID: 84937159356     PISSN: 03787966     EISSN: 21070180     Source Type: Journal    
DOI: 10.1007/s13318-015-0284-3     Document Type: Article

References (35)

1. Hastings MH, Reddy AB, Maywood ES. A clockwork web: circadian timing in brain and periphery, in health and disease. Nat Rev Neurosci. 2003;4(8):649–61.
2. Martin RJ, Banks-Schlegel S. Chronobiology of asthma. Am J Respir Crit Care Med. 1998;158(3):1002–7.
3. Smolensky MH, Lemmer B, Reinberg AE. Chronobiology and chronotherapy of allergic rhinitis and bronchial asthma. Adv Drug Deliv Rev. 2007;59(9–10):852–82.
4. Smolensky MH, Reinberg A, Labrecque G. Twenty-four hour pattern in symptom intensity of viral and allergic rhinitis: treatment implications. J Allergy Clin Immuno. 1995;95(5 Pt 2):1084–96.
5. Portaluppi F, Hermida RC. Circadian rhythms in cardiac arrhythmias and opportunities for their chronotherapy. Adv Drug Deliv Rev. 2007;59(9–10):940–51.
6. Portaluppi F, Lemmer B. Chronobiology and chronotherapy of ischemic heart disease. Adv Drug Deliv Rev. 2007;59(9–10):952–65.
7. Levi F, Focan C, Karaboue A, de la Valette V, Focan-Henrard D, Baron B, Kreutz F, Giacchetti S. Implications of circadian clocks for the rhythmic delivery of cancer therapeutics. Philos Trans A Math Phys Eng Sci. 2008;366(1880):3575–98.
8. Savvidis C, Koutsilieris M. Circadian rhythm disruption in cancer biology. Mol Med. 2012;18:1249–60.
9. Ayala DE, Hermida RC. Sex differences in the administration time-dependent effects of low-dose aspirin on ambulatory blood pressure in hypertensive subjects. Chronobiol Int. 2010;27(2):345–62.
10. Hermida RC, Ayala DE, Mojon A, Fernandez JR. Ambulatory blood pressure control with bedtime aspirin administration in subjects with prehypertension. Am J Hypertens. 2009;22(8):896–903.
11. Hermida RC, Ayala DE, Mojón A, Chayán L, Domínguez MJ, Fontao MJ, et al. Comparison of the effects on ambulatory blood pressure of awakening versus bedtime administration of torasemide in essential hypertension. Chronobiol Int. 2008;25(6):950–70.
12. Hermida RC, Ayala DE. Chronotherapy with the angiotensinconverting enzyme inhibitor ramipril in essential hypertension:improved blood pressure control with bedtime dosing. Hypertension. 2009;54(1):40–6.
13. Hermida RC, Ayala DE, Fontao MJ, Mojon A, Fernandez JR. Chronotherapy with valsartan/amlodipine fixed combination: improved blood pressure control of essential hypertension with bedtime dosing. Chronobiol Int. 2010;27(6):1287–303.
14. Buttgereit F, Doering G, Schaeffler A, Witte S, Sierakowski S, Gromnica-Ihle E, et al. Targeting pathophysiological rhythms: prednisone chronotherapy shows sustained efficacy in rheumatoid arthritis. Ann Rheum Dis. 2010;69(7):1275–80.
15. Tharavanij T, Wongtanakarn S, Lerdvuthisopon N, Teeraaunkul S, Youngsriphithak P, Sritipsukho P. Lipid lowering efficacy between morning and evening simvastatin treatment: a randomized double-blind study. J Med Assoc Thail. 2010;937 (suppl):S109–13.
16. Almeida L, Loureiro AI, Vaz-da-Silva M, Torrão L, Maia J, Fernandes-Lopes C. Chronopharmacology of nebicapone, a new catechol-O-methyltransferase inhibitor. Curr Med Res Opin. 2010;26(5):1097–108.
17. Okeahialam B, Ohihoin E, Ajuluchukwu J. Chronotherapy in Nigerian hypertensives. Ther Adv Cardiovasc Dis. 2011;5(2):113–8.
18. Harris B, Song R, Soong SJ, et al. Relationship between dihydropyrimidine dehydrogenase activity and plasma 5-fluorouracil levels with evidence for circadian variation of enzyme activity and plasma drug levels in cancer patients receiving 5-fluorouracil by protracted continuous infusion. Cancer Res. 1990;50(1):197–201.
19. Zhou C, Wu YL, Chen G, Feng J, Liu XQ, Wang C, et al. Erlotinib versus chemotherapy as first-line treatment for patients with advanced EGFR mutation-positive non-small-cell lung cancer (OPTIMAL, CTONG-0802): a multicentre, open-label, randomised, phase 3 study. Lancet Oncol. 2011;12(8):735–42.
20. Filipski E, Lemaigre G, Liu XH, Méry-Mignard D, Mahjoubi M, Lévi F. Circadian rhythm of irinotecan tolerability in mice. Chronobiol Int. 2004;21(4–5):613–30.
21. Portaluppi F, Smolensky MH, Touitou Y. Ethics and methods for biological rhythm research on animals and human beings. Chronobiol Int. 2010;27(9–10):1911–29.
22. Tampellini M, Filipski E, Liu XH, Lemaigre G, Li XM, Vrignaud P, et al. Docetaxel chronopharmacology in mice. Cancer Res. 1998;58:3896–904.
23. Zhao J, Lu J, Yang H-Y, Zhao J-M, Zhai J-M, Li S, et al. A comparative study on the ways of building the Lewis lung carcinoma animal models. Cancer Res Clin. 2008;20(7):439–41.
24. Faivre L, Gomo C, Mir O, Taieb F, Schoemann-Thomas A, Ropert S, et al. A simple HPLC-UV method for the simultaneous quantification of gefitinib and erlotinib in human plasma. J Chromatogr B. 2011;879(23):2345–50.
25. Schmutz I, Albrecht U, Ripperger JA. The role of clock genes and rhythmicity in the liver. Mol Cell Endocrinol. 2012;349(1):38–44.
26. Zhang YK, Yeager RL, Klaassen CD. Circadian expression profiles of drug-processing genes and transcription factors in mouse liver. Drug Metab Dispos. 2009;37(1):106–15.
27. Yanagimoto T, Itoh S, Muller-Enoch D, Kamataki T. Mouse liver cytochrome P-450 (P-450IIIAM1): its cDNA cloning and inducibility by dexamethasone. Biochim Biophys Acta. 1992;1130(3):329–32.
28. Takiguchi T, Tomita M, Matsunaga N, Nakagawa H, Koyanagi S, Ohdo S. Molecular basis for rhythmic expression of CYP3A4 in serum-shocked HepG2 cells. Pharmacogenet Genomics. 2007;17(12):1047–56.
29. Kiyohara YB, Nishii K, Ukai-Tadenuma M, Ueda HR, Uchiyama Y, Yagita K. Detection of a circadian enhancer in the mDbp promoter using prokaryotic transposon vector-based strategy. Nucleic Acids Res. 2008;36(4):e23.
30. Ripperger JA, Schibler U. Rhythmic CLOCK-BMAL1 binding to multiple Ebox motifs drives circadian Dbp transcription and chromatin transitions. Nat Genet. 2006;38(3):369–74.
31. Stratmann M, Stadler F, Tamanini F, van der Horst GT, Ripperger JA. Flexible phase adjustment of circadian albumin D site-binding protein (DBP) gene expression by CRYPTOCHROME1. Genes Dev. 2010;24(12):1317–28.
32. Min DI, Chen HY, Lee MK, Ashton K, Martin MF. Time-dependent disposition of tacrolimus and its effect on endothelin-1 in liver allograft recipients. Pharmacotherapy. 1997;17(3):457–63.
33. Vignati LA, Bogni A, Grossi P, Monshouwer M. A human and mouse pregnane X receptor reporter gene assay in combination with cytotoxicity measurements as a tool to evaluate species-specific CYP3A induction. Toxicology. 2004;199(1):23–33.
34. Ben-Cherifa W, Dridi I, Aouam K, Ben-Attia M, Reinberg A, Boughattas NA. Circadian variation of valproic acid pharmacokinetics in mice. Eur J Pharm Sci. 2013;49(4):468–73.
35. Baraldo M. The influence of circadian rhythms on the kinetics of drugs in humans. Expert Opin Drug Metab Toxicol. 2008;4(2):175–92.